MedPath

Colonic stenting or surgery in left sided colonic obstruction for disseminated incurable colorectal cancer: a multicenter randomised trial.

Suspended
Conditions
incurable left-sided colonic cancer
Registration Number
NL-OMON21491
Lead Sponsor
Prof. Gunning-Schepers, MD, Ph.D.Chaiman Board of DirectorsPO Box 226601100 DD Amsterdam
Brief Summary

Endoscopy(begin 2008) Stent-in I study

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
Not specified
Target Recruitment
180
Inclusion Criteria

1. Left sided colonic cancer (from left flexure to > 10 cm of anus);

2. Diagnosis histological proven;

Exclusion Criteria

1. Potentially curable disease;

2. ASA IV or V;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Total hospital free survival in good health (corrected for days with a WHO performance status > 1);<br /><br>2. Integral costs (product of volume consumed care and prices of means (personnel, overhead, material and investments).
Secondary Outcome Measures
NameTimeMethod
1. Procedural related hospital stay and mortality and morbidity;<br /><br>2. Efficacy of palliation of (imminent) obstruction (complaints, secondary operation or stent placement);<br /><br>3. Quality of life.
© Copyright 2025. All Rights Reserved by MedPath